T 2524/19 (Mammalian Cell Culture/AMGEN) of 06.10.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T252419.20221006
- Date of decision
- 6 October 2022
- Case number
- T 2524/19
- Petition for review of
- -
- Application number
- 12738674.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- MAMMALIAN CELL CULTURE
- Applicant name
- Amgen Inc.
- Opponent name
- Strawman Limited
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention Art 84Rules of procedure of the Boards of Appeal Art 11Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Main request and auxiliary requests 1, 1a, 2, 2a, 3, 3a and 4 - Inventive step (no)
Auxiliary request 3b - added subject-matter (yes)
Auxiliary requests 5 to 7 - clarity (no)
Remittal (no) - Catchword
- -
- Cited cases
- T 0967/97T 0578/06T 0021/08T 0716/08T 1742/12T 0405/14T 1174/15T 0418/17T 1174/18T 1012/19
- Citing cases
- -
Order
For these reasons it is decided that:
1. The appealed decision is set aside.
2. The patent is revoked.